Teladoc,Inc. (NYSE:TDOC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

ME Staff 8-k
-
0

Teladoc,Inc. (NYSE:TDOC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 9.01.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Effective September 18, 2017, the Board of Directors (the “Board”) of Teladoc, Inc. (the “Company”) increased the number of directors on the Board to eleven and appointed Mr. Brian McAndrews as a director of the Company. Mr. McAndrews will serve on the Board’s Audit and Compensation Committees.The Board has determined that Mr. McAndrews is an independent director within the meaning of the New York Stock Exchange listing standards.

There are no arrangements or understandings between Mr. McAndrews and any other person to which he was selected as a director.There are no other transactions involving the Company and Mr. McAndrews that the Company would be required to report to Item 404(a) of Regulation S-K.

Mr. McAndrews will have the same director indemnification arrangement as do the Company’s other directors, the form of agreement for which was filed with the SEC on June 18, 2015 as Exhibit 10.7 to the Company’s Amendment No. 3 to Registration Statement on Form S-1.Mr. McAndrews will be eligible to participate in the compensation arrangements and programs that are established for the Company’s non-employee directors, as in effect from time to time.

Item 9.01Regulation FD

On September 18, 2017, the Company issued a press release regarding the matter discussed in Item 9.01 of this Current Report.A copy of the press release is furnished herewith as Exhibit 99.1.

The information furnished under this Item 9.01 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01.Financial Statements and Exhibits.

(d)Exhibits.

ExhibitNo.

Description

99.1*

Teladoc,Inc. press release, dated September 18, 2017.

* Furnished herewith.


Teladoc, Inc. Exhibit
EX-99.1 2 tdoc-20170918ex99112edfe.htm EX-99.1 tdoc_EX_99_1 Exhibit 99.1     For Immediate Release   Teladoc Appoints Former Pandora CEO Brian McAndrews to Board of Directors   PURCHASE,…
To view the full exhibit click here

About Teladoc,Inc. (NYSE:TDOC)

Teladoc, Inc., together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. Its enterprise scale platform is offered for real-time sharing of clinical and non-clinical data in real time among the Teladoc constituents, which include Members, Providers, physician network operations center staff, nurses, SureScripts for electronic medication prescription writing, routing and fulfillment and health plans for claims processing, clinical summaries and clinical alerts.